Publications by authors named "Raul Altman"

Claim this Profile
[
[Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT)].
Cecilia Guillermo-Esposito, Patricia Casais, Gabriela Cesarman-Maus, Fernanda Andrade-Orsi, Rosario Martínez-Rovira, Raúl Altman

Arch Cardiol Mex· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs.
Raul Altman, Claudio Daniel Gonzalez

Thromb J· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs.
Raul Altman, Claudio Daniel Gonzalez

Thromb J· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New oral anticoagulants: are coagulation units still required?
Raul Altman

Thromb J· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin and the harmful effect of NSAIDs.
Raul Altman, Claudio D Gonzalez

Am J Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study.
Raul Altman, Ana J Rivas, Claudio D Gonzalez

Thromb J· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter by Altman and Gonzalez regarding article, "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study".
Raul Altman, Claudio D Gonzalez

Circulation· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective.
Raul Altman, Hector O Vidal

Thromb J· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
Raul Altman, Alejandra Scazziota, Maria de Lourdes Herrera, Claudio D Gonzalez

Thromb J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy.
Raul Altman

Thromb J· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis.
Raul Altman, Alejandra Silvia Scazziota, Maria de Lourdes Herrera, Claudio Gonzalez

Thromb J· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?
Raul Altman

Nat Clin Pract Cardiovasc Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab does not inhibit the increase of thrombin generation produced in platelet-rich plasma in vitro by sodium arachidonate or tissue factor.
Raul Altman, Alejandra Scazziota, Silvina Santoro, Claudio Gonzalez

Clin Appl Thromb Hemost· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of "thrombosis in clinical practice".
Raul Altman

Thromb J· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
Raul Altman, Héctor L Luciardi, Juan Muntaner, Ramón N Herrera

Thromb J· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.
Raul Altman

Thromb J· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute coronary disease Athero-Inflammation: Therapeutic approach.
Raul Altman

Thromb J· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Role of anti-inflammatory drugs in the treatment of acute coronary syndromes. From athero-inflammation to athero-thrombosis].
Raúl Altman, Alejandra Scazziota

Rev Esp Cardiol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin resistance.
Jorge Rouvier, Alejandra Scazziota, Raúl Altman

Circulation· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinogen: intra-individual variability in patients with arterial disease and in patients with cardiac valve replacements.
Jorge Rouvier, Claudio González, Alejandra Scazziota, Raúl Altman

Isr Med Assoc J· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
Raul Altman, Hector L Luciardi, Juan Muntaner, Fatima Del Rio, Sofia G Berman

Circulation· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilitated thrombolysis: dethrombosis?
Héctor Luciardi, Sofía Berman, Juan Muntaner, Fernando de la Serna, Raúl Altman

Clin Appl Thromb Hemost· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease.
Raúl Altman, Jorge Rouvier, Alejandra Scazziota, Claudio Gonzalez

Inflammation· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis